Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$0.71 - $2.43 $7,372 - $25,233
-10,384 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.31 - $5.13 $23,987 - $53,269
10,384 New
10,384 $25,000
Q4 2021

Feb 14, 2022

SELL
$4.45 - $8.09 $127,416 - $231,640
-28,633 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$6.94 - $8.85 $107,209 - $136,714
15,448 Added 117.16%
28,633 $224,000
Q1 2021

May 17, 2021

BUY
$8.78 - $12.8 $115,764 - $168,768
13,185 New
13,185 $149,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.